Voyageur Pharmaceuticals (VM) Stock Statistics & Valuation Metrics

Voyageur Pharmaceuticals has a market cap or net worth of C$21.43M. The enterprise value is C$21.20M.

Voyageur Pharmaceuticals has 178,586,980 shares outstanding. The number of shares has decreased by -2.65% in one year.

Voyageur Pharmaceuticals’s return on equity (ROE) is -2.82 and return on invested capital (ROIC) is -273.32%.

The current PE Ratio of Voyageur Pharmaceuticals is ―. Voyageur Pharmaceuticals’s PEG ratio is -0.11.

In the last 12 months, Voyageur Pharmaceuticals had revenue of 11.69K and earned -3.53M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -2.89M and capital expenditures 7.00, giving a free cash flow of -2.89M billion.

Voyageur Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Voyageur Pharmaceuticals upcoming earnings date is Apr 24, 2026, TBA (Confirmed).

Voyageur Pharmaceuticals as a current ratio of 0.33, with Debt / Equity ratio of 3.19%

In the past 12 months, Voyageur Pharmaceuticals has paid 0.00 in taxes.

Voyageur Pharmaceuticals EV to EBITDA ratio is -7.68, with an EV/FCF ratio of -9.37.

Voyageur Pharmaceuticals has C$267.05K in cash and marketable securities with C$40.00K in debt, giving a net cash position of C$227.05K billion.

Gross margin is -10466.55%, with operating margin of -30231.56%, and net profit margin of -30231.56%.

The average price target for Voyageur Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―